Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| NextCure, Inc.NXTC · Entity 7461 | Chief Medical Officer | March 29, 2024 | April 02, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
NextCure, Inc.
Report date March 29, 2024 · Filed April 02, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.23 · Expires 2034-03-28 | Direct | 93,900 |
Reported balance
After 2024-03-29 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-03-29 · Grant · Acquired 93,900 · Balance 93,900 F1: The option vests in full on the one year anniversary of the grant, March 29, 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: The option vests in full on the one year anniversary of the grant, March 29, 2025.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 29, 2024 Filed Apr 2, 2024 20:43 UTC | NextCure, Inc. NXTC · Entity 7461 | GrantEmployee Stock Option (Right to Buy) · Derivative | 93,900 | $0.00 Strike: $2.23 | $0.00 |
DisclosureSEC source: 0000905148-24-001053 · form4.xml · derivative · entry 1 Myint Han · CIK 0001840942 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,900 Underlying: Common Stock · 93,900 shares Expires 2034-03-28 F1 · derivative.exercise_date: The option vests in full on the one year anniversary of the grant, March 29, 2025. Read SEC document |
| January 31, 2024 Filed Feb 1, 2024 21:45 UTC | NextCure, Inc. NXTC · Entity 7461 | GrantEmployee Stock Option (Right to Buy) · Derivative | 117,375 | $0.00 Strike: $1.22 | $0.00 |
DisclosureSEC source: 0000905148-24-000394 · form4.xml · derivative · entry 1 Myint Han · CIK 0001840942 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 117,375 Underlying: Common Stock · 117,375 shares Expires 2034-01-30 F1 · derivative.exercise_date: One fourth of the option vests on January 31, 2025. The remainder vests in 36 monthly installments beginning on February 28, 2025. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 23:01 UTC | NextCure, Inc. NXTC · Entity 7461 | GrantEmployee Stock Option (Right to Buy) · Derivative | 135,000 | $0.00 Strike: $1.55 | $0.00 |
DisclosureSEC source: 0001140361-23-009492 · form4.xml · derivative · entry 1 Myint Han · CIK 0001840942 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,000 Underlying: Common Stock · 135,000 shares Expires 2033-02-27 F1 · derivative.exercise_date: One fourth of the option vests on February 28, 2024. The remainder vests in 36 monthly installments beginning on March 28, 2024. Read SEC document |
| January 31, 2022 Filed Feb 2, 2022 21:15 UTC | NextCure, Inc. NXTC · Entity 7461 | GrantEmployee Stock Option (Right to Buy) · Derivative | 103,600 | $0.00 Strike: $5.57 | $0.00 |
DisclosureSEC source: 0000905148-22-000157 · form4.xml · derivative · entry 1 Myint Han · CIK 0001840942 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,600 Underlying: Common Stock · 103,600 shares Expires 2032-01-30 F1 · derivative.exercise_date: One fourth of the option vests on January 31, 2023. The remainder vests in 36 monthly installments beginning on February 28, 2023. Read SEC document |
| January 13, 2021 Filed Jan 19, 2021 22:21 UTC | NextCure, Inc. NXTC · Entity 7461 | GrantEmployee Stock Option (Right to Buy) · Derivative | 200,000 | $0.00 Strike: $12.09 | $0.00 |
DisclosureSEC source: 0001123292-21-000085 · edgar.xml · derivative · entry 1 Myint Han · CIK 0001840942 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2031-01-12 F1 · derivative.exercise_date: One fourth of the option vests on January 11, 2022. The remainder vests in 36 monthly installments beginning on February 11, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.